Advanced Biomed Inc. 是一家投資控股公司,於台灣從事微流控生物晶片技術的研發,並將其應用於精準腫瘤學檢測、診斷及治療。公司總部位於紐約州紐約市。
財務指標
營業收入
2026-09-30
$4.03K
2026-03-31
$0
2025-12-31
$0
2025-09-30
$17.2K
營業支出
2026-09-30
$180.77K
2026-03-31
$519.83K
2025-12-31
$12.31K
2025-09-30
$523.91K
淨利潤
2026-09-30
-$429.96K
2026-03-31
-$488.94K
2025-12-31
$220.94K
2025-09-30
-$386.9K
淨利潤率
2026-09-30
-10.65K%
2026-03-31
--
2025-12-31
--
2025-09-30
-2.24K%
每股收益
2026-09-30
--
2026-03-31
$-0.01
2025-12-31
$0.20
2025-09-30
$-0.03
息稅折舊攤銷前利潤
2026-09-30
-$176.73K
2026-03-31
-$479.5K
2025-12-31
-$12.31K
2025-09-30
-$475.92K
有效稅率
2026-09-30
0%
2026-03-31
--
2025-12-31
63.94%
2025-09-30
--
項目
2026-09-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$4.03K
$0
$0
$17.2K
營業支出
$180.77K
$519.83K
$12.31K
$523.91K
淨利潤
-$429.96K
-$488.94K
$220.94K
-$386.9K
淨利潤率
-10.65K%
--
--
-2.24K%
每股收益
--
$-0.01
$0.20
$-0.03
息稅折舊攤銷前利潤
-$176.73K
-$479.5K
-$12.31K
-$475.92K
有效稅率
0%
--
63.94%
--
常見問題
ADVB is a publicly traded equity security that represents an ownership stake in its underlying company. The stock trades on a U.S. exchange, and its price reflects investor supply and demand throughout each trading session. For the most current details about ADVB, including its share price, exchange listing, and corporate profile, refer to the stock data displayed on this page. ADVB's common shares may provide voting rights and exposure to the company's financial performance.
ADVB's share price can move in response to company-specific news such as earnings releases, guidance updates, management changes, and strategic announcements. Broader forces also matter, including interest rates, inflation, sector trends, and overall market sentiment. Changes in the competitive landscape or regulatory environment may influence ADVB as well. Because these variables shift over time, the latest ADVB price and related data on this page offer the most current snapshot of how investors are reacting.
Recent performance for ADVB is shown in the price chart and performance figures on this page, which typically include daily, weekly, and year-to-date changes. Those numbers update as the market moves, so check the latest ADVB data here rather than relying on older references. Performance can be influenced by company news, sector trends, and overall market conditions. Reviewing the displayed price history alongside recent ADVB headlines can help put short-term moves into context.
Valuation involves comparing ADVB's market price with financial fundamentals such as earnings, revenue, book value, and cash flow. Common tools include the price-to-earnings ratio, price-to-sales ratio, and price-to-book ratio, each offering a different perspective. Analysts also consider growth rates and industry peers. Because these metrics fluctuate with market prices and reported results, use the latest ADVB financial data and valuation ratios shown on this page rather than fixed numbers.
Shares of ADVB can generally be bought and sold through a brokerage account that offers access to U.S. equity markets. Orders may be placed during regular market hours, and some brokers also support extended-hours trading, subject to their rules and liquidity conditions. The exact exchange where ADVB is listed is shown in the stock data on this page. Trading fees, order types, and settlement timelines depend on the brokerage you use.
Investing in ADVB carries market risk, as the share price can decline due to broad market downturns or sector-specific pressures. Company-level risks include weaker-than-expected financial results, operational challenges, competitive threats, and management decisions that may not produce anticipated benefits. Liquidity and volatility can also affect how easily shares trade near expected prices. The specific risk profile for ADVB depends on its business and financial condition, so review its latest filings and the data on this page.